Compared to Estimates, GE HealthCare (GEHC) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/28/26
GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 10/28/26
GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?Zacks Investment Research • 10/27/26
GE HealthCare announces five new global collaborations to advance the next generation of theranostics imagingBusiness Wire • 10/20/26
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in EuropeZacks Investment Research • 10/20/26
GE HealthCare expands general imaging ultrasound portfolio with LOGIQ Focus, elevating everyday ultrasound performanceBusiness Wire • 10/19/26
Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flowBusiness Wire • 10/16/26
GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68Business Wire • 10/15/26
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmGlobeNewsWire • 10/05/26
GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma businessReuters • 10/05/26
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationGlobeNewsWire • 10/05/26
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.Business Wire • 10/05/26
GE HealthCare is expected to announce Monday a $945 million cash purchase of a manufacturer of radioactive substances used in medical imaging procedures like PET scansWSJ • 10/05/26
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzGlobeNewsWire • 10/02/26